Ocular pharmacology of bicyclic hexahydroaporphines

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 27, Issue 2, 2005, Pages 87-93

  Ohia, S E ^a   Zhan, G L ^b   LeDay, A M ^c   Opere, C A ^c   Kulkarni, K H ^a   Harris, L C ^c   Roche, V F ^c  

^a UNIVERSITY OF HOUSTON   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bicyclic hexahydroaporphines; Intraocular pressure; Nitric oxide; Ocular smooth muscle; Prostaglandins

Indexed keywords

APORPHINE DERIVATIVE; BICYCLIC HEXAHYDROAPORPHINE; CARBACHOL; LIPOXYGENASE; N METHYLHEXAHYDROAPORPHINE; N METHYLHEXAHYDROAPORPHINE PHENOL; NITRIC OXIDE; NORHEXAHYDROAPORPHINE; PHOSPHOLIPASE A2; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; SCAVENGER; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; AQUEOUS HUMOR FLOW; AQUEOUS HUMOR FORMATION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; COW; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG INHIBITION; DRUG MECHANISM; DRUG STRUCTURE; INTRAOCULAR PRESSURE; IRIS; IRIS SMOOTH MUSCLE CONTRACTION; NONHUMAN; POSTSYNAPTIC POTENTIAL; RABBIT; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE CONTRACTION;

ANIMALS; APORPHINES; BICYCLO COMPOUNDS; CATTLE; CYCLOOXYGENASE INHIBITORS; EYE; FLURBIPROFEN; INTRAOCULAR PRESSURE; IRIS; MALE; MUSCLE, SMOOTH; OCULAR HYPOTENSION; RABBITS;

EID: 17044366614     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2005.27.2.876283     Document Type: Article

References (18)

1. Saha, S.L., Zhan, G., Tang, L. et al. Bicyclic derivatives of hexahydroaporphine: Novel agents that lower intraocular pressure. J Ocul Pharmacol Ther 1997, 13: 497-505.
2. Saha, S.L., Roche, V.F., Pendola, K. et al. Synthesis and in vitro platelet aggregation and TP receptor binding studies on bicyclic 5,8-ethanooctahydroisoquinolines and 5,8-ethanotetrahydroisoquinolines. Bioorg Med Chem 2002, 10: 2779-93.
3. Tran, N.D., Brosnahan, K.M., Roche, V.F. Synthesis of a secondary desmethyl and a tertiary N-cyclopropylmethyl bridged hexahydroaporphine as precursors to bicyclic opioid ligands. J Pharm Sci 1990, 79: 1034-7.
4. Roche, V.F., Roche, E.B., Nagel, D.L. et al. Studies in the synthesis of C ring bridged morphinans 2. The synthesis and structural verification of a novel 3,11c-ethano-10-hydroxy-6-methyl-1,2,3,3a,11b,11c-hexahydroaporphine. J Org Chem 1984, 49: 3881-7.
5. Al-zadjali, K., Imler, M., Ohia, S.E. Inhibitory effect of prostaglandin on dopamine release from the retina. Gen Pharmacol 1994, 25: 289-96.
6. 3H]D-aspartate release from bovine isolated retinae. Curr Eye Res 2004, 28: 367-72.
7. Thompson, H.S. Diagnosing Horner's syndrome. Tran Am Acad Ophthalmol Otolaryngol 1977, 83: OP840-OP842.
8. Jones, R.F., Maurice, D.M. New methods of measuring the rate of aqueous flow in man with fluorescein. Exp Eye Res 1966, 5: 208-20.
9. Yablonski, M.E., Hayaski, M., Cook, D.. et al. Fluorophotometric study of intravenous carbonic anhydrase inhibitors in rabbits. Ophthalmol Vis Sci 1987, 28: 2076-82.
10. Graham, J., Awe, S.O., LeDay, A.M. et al. Effect of inhibition of cyclooxygenase on pre- and postjunctional actions of peroxides in the iris-ciliary body. Neurochem Res 2000, 25: 519-25.
11. Marathe, G.K., Yousufzai, S.Y., Abdel-Latif, A.A. Mediation by prostaglandins of the stimulatory effect of substance P on cyclic AMP production in dog iris sphincter smooth muscle. Biochem Pharmacol 1996, 25; 52: 1261-9.
12. Kashiwagi, K., Kanai, N., Tsuchida, T. et al. Comparison between isopropyl unoprostone and latanoprost by prostaglandin E(2)induction, affinity to prostaglandin transporter, and intraocular metabolism. Exp Eye Res 2002, 74: 41-9.
13. Taniguchi, H., Uenoyama, Y., Miyamoto, Y. et al. The lipoxygenase pathways are involved in LH-stimulated progesterone production in bovine corpus luteum. Prostaglandins Other Lipid Mediat 2002, 67: 49-60.
14. Tanaka, H., Jing, L., Takahashi, S. et al. The possible role of nitric oxide in relaxations and excitatory neuroeffector transmission in the cat airway. J Physiol 1996, 493: 785-91.
15. Chiou, G.C. Review: Effects of nitric oxide on eye diseases and their treatment. J Ocul Pharmacol Ther 2001, 17: 189-98.
16. Kotikoski, H., Kankuri, E., Vapaatalo, H. Incubation of porcine iris-ciliary bodies to study the mechanisms by which nitric oxide donors lower intraocular pressure. Med Sci Monit 2003, 9: BR1-BR7.
17. Gallar, J., Liu, J.H. Stimulation of cervical sympathetic nerves increases intraocular pressure. Invest Ophthalmol Vis Sci 1993, 34: 596-605.
18. Stjernschantz, J. Studies on ocular inflammation and development of a prostaglandin analogue for glaucoma treatment. Exp Eye Res 2004, 78: 759-66.